NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Multiple Sclerosis (https://www.neurotalk.org/multiple-sclerosis/)
-   -   MS Attacks More Than Myelin (https://www.neurotalk.org/multiple-sclerosis/88617-ms-attacks-myelin.html)

gonnamakeit 06-03-2009 08:30 PM

I read the article. It appears to be about the only thing for SPMS and I would try it if I could find a doctor to prescribe it. One major problem is that MSG is in almost everything!!

gmi


Quote:

Originally Posted by jackD (Post 518949)
NO. I never considered taking it(LDN) because I was on Avonex for over 10 years.

The info that it was found to counter Glutamate nerve toxicity is very new and I will post it here as soon a I can find it again.

FounD It!!!!
.
.
http://autoimmunedisease.suite101.co...rosis_variants
.
jackD


jackD 06-03-2009 08:47 PM

Lower Glutamate levels...
 
I have been researching how to reduce Glutamate levels and thus Glutamate nerve toxicity for some time. I have not had any new or enhancing lesions in over 8 years but I am having increasing problems with my legs and mobility.

I think that now that the Myelin has been removed from my nerves that they are now "lunch" for some nasty critters and the Glutamate factor seems to be the number #1 suspect.

The body does produce a substance to counter this kind of damage but it cannot be taken as a supplement or medication.

I do have short list of "things" that may cause the body to produce more of this substance. My recent computer crash and a few trips to the emergency room for things not directly related to MS has slowed down my research and prevented me from posting on this subject.

I will try to post individually what I have found and what I am taking in the hope? that it will help. Obviously avoiding things that elevate Glutamate levels (like MSG) comes first.

jackD

jackD 06-03-2009 09:18 PM

Quote:

Originally Posted by Bearygood (Post 518924)
Incredibly timely given my doctor's appointment today regarding my new "black hole" lesion. I'm beat but I'm going to address this more when I further update that thread. I believe this is probably correct. But although obviously not good news, not necessarily as bleak as it sounds -- remember that depending upon where the damage is, the brain can be remarkable in re-routing itself to compensate (neuroplasticity). Many MS folks with even axonal damage are asymptomatic.

You are right about the brains ability to reroute itself BUT that compensatation ability does not work well in the spine.

So the 2nd stage of MS where the axons are attacked can cause some serious damage for which the body cannot compensate and the net effect is loss of lower limb strength.

jackD

jackD 06-04-2009 01:39 PM

Both
 
Interesting to note that Glutamate attacks BOTH axons and myelin cells.

jackD


Neural Transm Suppl. 2000;(60):375-85. Related Articles, L

Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?

Werner P, Pitt D, Raine CS.

Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.


Glutamate excitotoxicity mediated by the AMPA/kainate-type of glutamate receptors is known not only to damage neurons but also the myelin-producing cell of the central nervous system (CNS), the oligodendrocyte.

In Multiple Sclerosis (MS), myelin, oligodendrocytes and axons are lost or damaged as a result of an inflammatory attack on the CNS. Activated immune cells produce glutamate in large quantities by deamidating glutamine via glutaminase.

Thus, we hypothesized that during inflammation in MS, glutamate excitotoxicity may contribute to the lesion. This was addressed by treating mice sensitized to develop acute experimental autoimmune encephalomyelitis (EAE) with an AMPA/kainate antagonist, NBQX.

Treatment resulted in substantial amelioration of disease, increased oligodendrocyte survival and reduced axonal damage, as indicated by the levels of dephosphorylated neurofilament-H. Despite the clinical differences, NBQX-treatment had no effect on lesion size and did not reduce the degree of CNS inflammation. In addition, NBQX did not alter the proliferative activity of antigen-primed T cells in vitro, further indicating a lack of effect at the level of the immune system.

In separate studies, infiltrating immune cells present in perivascular cuffs, commonly the site of entry for invading immune cells, were found to express glutaminase in abundance, supporting the production of glutamate in inflammatory lesions.

Thus, glutamate excitotoxicity appears to be an important mechanism in autoimmune demyelination and its prevention with AMPA/kainate antagonists may prove to be an effective therapy for MS.

PMID: 11205156 [PubMed]

gonnamakeit 06-04-2009 02:19 PM

From what you have researched, does glutamate appear to be the main culprit in nerve damage? If so, people really need to stop eating anything that contains MSG.

If one googles MSG, there are tons of places which list foods that always or usually contain this ingredient. I know that I get tremendous headaches after ingesting the stuff.

gmi

Quote:

Originally Posted by jackD (Post 519245)
Interesting to note that Glutamate attacks BOTH axons and myelin cells.

jackD


Neural Transm Suppl. 2000;(60):375-85. Related Articles, L

Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?

Werner P, Pitt D, Raine CS.

Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.


Glutamate excitotoxicity mediated by the AMPA/kainate-type of glutamate receptors is known not only to damage neurons but also the myelin-producing cell of the central nervous system (CNS), the oligodendrocyte.

In Multiple Sclerosis (MS), myelin, oligodendrocytes and axons are lost or damaged as a result of an inflammatory attack on the CNS. Activated immune cells produce glutamate in large quantities by deamidating glutamine via glutaminase.

Thus, we hypothesized that during inflammation in MS, glutamate excitotoxicity may contribute to the lesion. This was addressed by treating mice sensitized to develop acute experimental autoimmune encephalomyelitis (EAE) with an AMPA/kainate antagonist, NBQX.

Treatment resulted in substantial amelioration of disease, increased oligodendrocyte survival and reduced axonal damage, as indicated by the levels of dephosphorylated neurofilament-H. Despite the clinical differences, NBQX-treatment had no effect on lesion size and did not reduce the degree of CNS inflammation. In addition, NBQX did not alter the proliferative activity of antigen-primed T cells in vitro, further indicating a lack of effect at the level of the immune system.

In separate studies, infiltrating immune cells present in perivascular cuffs, commonly the site of entry for invading immune cells, were found to express glutaminase in abundance, supporting the production of glutamate in inflammatory lesions.

Thus, glutamate excitotoxicity appears to be an important mechanism in autoimmune demyelination and its prevention with AMPA/kainate antagonists may prove to be an effective therapy for MS.

PMID: 11205156 [PubMed]


Lady 06-05-2009 01:31 AM

As a child I was ingesting tons of MSG. My Mother would buy a HUGE box of Accent (a flavor enhancer). She poured it over all the food she cooked and served. She got early Alzheimer's Disease and I got MS. Hmm :confused:

Lady 06-06-2009 01:07 AM

Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, autism, some forms of mental retardation and Alzheimer's disease.
************************************************** ******
Glutamic acid is often used as a food additive and flavour enhancer in the form of its sodium salt, monosodium glutamate (MSG).

All meats, poultry, fish, eggs, dairy products, as well as kombu are excellent sources of glutamic acid. Some protein-rich plant foods also serve as sources. Ninety-five percent of the dietary glutamate is metabolized by intestinal cells in a first pass.

http://en.wikipedia.org/wiki/Glutamate

jackD 06-07-2009 07:54 PM

Hate to point this out ...

BUT it is our own MS lesions that produce the Glutamate that causes all the axon/neuron damage.

Taking in more Glutamate from our diet is obviously not a good idea.

Here is how the Glutamate does the dastardly deed.

THE BELOW LINK IS VERY, VERY CRITICAL TO UNDERSTANDING HOW NEURONS DIE ie the Calcium connection!!!!


http://www.psychiatrist.com/pcc/brainstorm/br5806.htm (Glutamate assassin/excitotoxic neuron murder)


The Second Stage of MS is "The Degererative Stage" in which "excess Glutamate" runs wild on a killing spree. First phase, of course, is the "Inflammatory Stage".

http://home.ix.netcom.com/~jdalton/ms-two-stages.pdf

jackD

http://www.psychiatrist.com/pcc/brainstorm/br5904.htm (main article)


http://www.psychiatrist.com/pcc/brainstorm/br5906.htm (therapeutic potential)

jackD 06-07-2009 10:10 PM

counter Glutamate neuron toxicity
 
There are "THINGIES" that counter Glutamate neuron toxicity.

It does not take too much effort to do some simple searches to locate some of them.

I have found several supplements that I take each day however I have no human research data to show it makes a difference or is worth the expense.

I will do a quick post of some of the abstracts.

jackD

jackD 06-08-2009 12:52 AM

Tocotrienols defend the nervous system
 
Quote:

Originally Posted by jackD (Post 520567)
There are "THINGIES" that counter Glutamate neuron toxicity.

It does not take too much effort to do some simple searches to locate some of them.

I have found several supplements that I take each day however I have no human research data to show it makes a difference or is worth the expense.

I will do a quick post of some of the abstracts.

jackD

Here is one GOOD protector of neurons.

JackD

1: Ann N Y Acad Sci. 2004 Dec;1031:127-42.

Tocotrienol: the natural vitamin E to defend the nervous system?

Sen CK, Khanna S, Roy S.

Davis Heart & Lung Research Institute, 473 West 12th Avenue, The Ohio State
University Medical Center, Columbus, Ohio 43210, USA. sen-1@medctr.osu.edu

Vitamin E is essential for normal neurological function. It is the major
lipid-soluble, chain-breaking antioxidant in the body, protecting the integrity
of membranes by inhibiting lipid peroxidation. Mostly on the basis of symptoms
of primary vitamin E deficiency, it has been demonstrated that vitamin E has a
central role in maintaining neurological structure and function. Orally
supplemented vitamin E reaches the cerebrospinal fluid and brain. Vitamin E is a
generic term for all tocopherols and their derivatives having the biological
activity of RRR-alpha-tocopherol, the naturally occurring stereoisomer compounds
with vitamin E activity. In nature, eight substances have been found to have
vitamin E activity: alpha-, beta-, gamma- and delta-tocopherol; and alpha-,
beta-, gamma- and delta-tocotrienol. Often, the term vitamin E is synonymously
used with alpha-tocopherol. Tocotrienols, formerly known as zeta, , or
eta-tocopherols, are similar to tocopherols except that they have an isoprenoid
tail with three unsaturation points instead of a saturated phytyl tail. Although
tocopherols are predominantly found in corn, soybean, and olive oils,
tocotrienols are particularly rich in palm, rice bran, and barley oils.
Tocotrienols possess powerful antioxidant, anticancer, and cholesterol-lowering
properties. Recently, we have observed that alpha-tocotrienol is multi-fold more
potent than alpha-tocopherol in protecting HT4 and primary neuronal cells
against toxicity induced by glutamate as well as by a number of other toxins. At
nanomolar concentration, tocotrienol, but not tocopherol, completely protected
neurons by an antioxidant-independent mechanism. Our current work identifies two
major targets of tocotrienol in the neuron: c-Src kinase and 12-lipoxygenase.
Dietary supplementation studies have established that tocotrienol, fed orally,
does reach the brain. The current findings point towards tocotrienol as a potent
neuroprotective form of natural vitamin E.

PMID: 15753140 [PubMed - indexed for MEDLINE]


1: Neuropharmacology. 2004 Nov;47(6):904-15.

Alpha-tocotrienol provides the most potent neuroprotection among vitamin E
analogs on cultured striatal neurons.

Osakada F, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A.

Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto
University, 46-29 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Oxidative stress and apoptosis play pivotal roles in the pathogenesis of
neurodegenerative diseases. We investigated the effects of vitamin E analogs on
oxidative stress and apoptosis using primary neuronal cultures of rat striatum.
A tocotrienol-rich fraction of edible oil derived from palm oil (Tocomin 50%),
which contains alpha-tocopherol, and alpha-, gamma- and delta-tocotrienols,
significantly inhibited hydrogen peroxide (H2O2)-induced neuronal death. Each of
the tocotrienols, purified from Tocomin 50% by high-performance liquid
chromatography, significantly attenuated H2O2-induced neurotoxicity, whereas
alpha-tocopherol did not. alpha-, gamma- and delta-Tocotrienols also provided
significant protection against the cytotoxicity of a superoxide donor, paraquat,
and nitric oxide donors, S-nitrosocysteine and 3-morpholinosydnonimine.
Moreover, tocotrienols blocked oxidative stress-mediated cell death with
apoptotic DNA fragmentation caused by an inhibitor of glutathione synthesis,
L-buthionine-[S,R]-sulfoximine. In addition, alpha-tocotrienol, but not gamma-
or delta-tocotrienol, prevented oxidative stress-independent apoptotic cell
death, DNA cleavage and nuclear morphological changes induced by a non-specific
protein kinase inhibitor, staurosporine. These findings suggest that
alpha-tocotrienol can exert anti-apoptotic neuroprotective action independently
of its antioxidant property. Among the vitamin E analogs examined,
alpha-tocotrienol exhibited the most potent neuroprotective actions in rat
striatal cultures.

PMID: 15527824 [PubMed - indexed for MEDLINE]


All times are GMT -5. The time now is 02:02 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.